Northern New England Accountable Care Collaborative selects Gold Standard Drug Database
- 06 Nov 2012
Elsevier's Gold Standard, a drug information provider, has announced that the Northern New England Accountable Care Collaborative, LLC, (NNEACC) has selected the Gold Standard Drug Database to deliver current and accurate drug data and drug decision support. Co-founded by Dartmouth Hitchcock, Eastern Maine Healthcare Systems, Maine Health and Dartmouth College, NNEACC develops, implements and evaluates new models of clinical care required to deliver on the Triple Aim â€“ better care, better health at lower cost.
The integration of the Gold Standard Drug Database module will allow the NNEACC to streamline and automate the process of integrating prescribing data with administrative and clinical information to provide a robust view of patient activity to clinicians.
The Gold Standard Drug Database will offer NNEACC drug pricing updates, therapeutic groupings of drug products, brand versus generic identifiers, and accurate information on generics. The Gold Standard Drug Database interacts intelligently with patient prescribing data to guide the clinician to an efficient and effective delivery of the patient's medication, assisting adherence to drug therapy for best health benefits. NNEACC will benefit from the database's modern technical architecture, combined with current, accurate content and built-in human logic for superior decision support, which distinguishes Gold Standard Drug Database from other drug compendia.
Led by Dr. David Wennberg, the NNEACC solution integrates administrative and clinical data sources in a proven data technology foundation with innovative analytics to provide focused and actionable information that supports clinicians and administrators as they manage care.
Eaton Apothecary selects PAC from Elsevier / Gold Standard and Glass Box Analytics
- 29 Jun 2012
Drug information provider Elsevier / Gold Standard, US, has announced that Holliston, Massachusetts-based pharmacy chain Eaton Apothecary has purchased the new Predictive Acquisition Cost (PAC), developed by Glass Box Analytics and exclusively sold by Elsevier / Gold Standard.
Introduced earlier this year, PAC is a new drug price type that more closely tracks true acquisition cost. PAC employs predictive analytics techniques to estimate acquisition cost considering various factors, including MAC benchmarks, published price lists, existing price benchmarks, drug dispensing metrics, supply-demand measures, and survey-based acquisition costs. Independent tests show that PAC tracks drug acquisition cost with sufficient accuracy to support pricing activity.
Eaton Apothecary has 16 locations, including traditional retail pharmacies and those focused on home delivery and specialised care. As a classic community-centered pharmacy, Eaton Apothecary prides itself for its commendable one-on-one service with patients. With a reputation in the industry as an early-adopter of new, enhanced technologies and marketplace trends, Eaton Apothecary selected PAC, adding to the companyâ€™s competitive edge.
The pharmacy chain plans to utilise PAC for reimbursement analysis, wholesaler request for proposal processes with standards for deviations from the PAC price type, and as a cash pricing base.
Elsevier / Gold Standard adds FSS pricing to enhance pricing analysis with ProspectoRx
- 04 Mar 2011
Elsevier / Gold Standard, a US-based developer of drug databases and medication management solutions, has announced several enhancements to its pricing tool, ProspectoRx. This includes the addition of Federal Supply Schedule (FSS) pricing to facilitate pricing analysis.
Other enhancements include multiple watch lists and enhanced price change notifications, a new label name search box for market class, along with an improved interface, help tab, and report download capabilities.
The rate and frequency at which drug prices change in today's competitive environment make current, accurate and easily accessible pricing information critical to success in the pharmaceutical industry, it has been observed. The addition of FSS pricing is projected to make ProspectoRx an even more comprehensive pricing and analytics tool by providing immediate access to competitive federal pricing, better marketplace knowledge and less time spent researching.
Derived from Elsevier / Gold Standard's Alchemy drug product and pricing files, ProspectoRx is said to include extensive information on brand and generic drugs, delivering immediate access to price changes and new product information. Pricing information that is already offered includes: reported Average Wholesale Price (AWP), Wholesale Acquisition Cost (WAC), Direct Price (DP), and Federal Upper Limit (CMS-FUL), as well as Calculated Average Wholesale Price (C-AWP) 1.20 and 1.25, and Calculated Federal Upper Limit (C-CMS-FUL).
Search for more Pricing tools
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.